YuanMing Capital
Overview
YuanMing Capital is a private equity firm specializing in healthcare investments, focusing on cross-border opportunities between the United States and China. The firm invests in therapeutics, medical devices, diagnostics, and healthcare service companies based in both countries. With offices in Beijing and New York City, YuanMing Capital leverages its deep understanding of both markets to identify and support innovative healthcare ventures. The firm's investment strategy encompasses various stages, including early-stage, growth, late-stage, pre-IPO, and buyout investments. YuanMing Capital seeks to partner with companies that have promising growth potential and align with its focus on healthcare innovation. The firm emphasizes a disciplined investment process and risk management framework to generate market-beating returns while maintaining prudent risk controls. YuanMing Capital has a track record of leading significant investments in the healthcare sector. Notably, in August 2015, the firm co-led a $200 million investment in Mevion Medical Systems, a leading provider of advanced proton therapy systems, aiming to accelerate its worldwide expansion. Concurrently, Mevion and the lead investors formed a joint venture in China to produce, sell, and service proton therapy systems for the Chinese market. In June 2015, YuanMing Capital co-led a $27 million Series A investment in Waveguide, a Cambridge, MA-based diagnostic device maker. These investments reflect the firm's commitment to advancing healthcare technologies and services in both the US and China. YuanMing Capital's management team comprises professionals with strong academic backgrounds from top-class universities and extensive experience in world-renowned medical R&D institutes. The team has successfully led or participated in the research and investment of new medicines with international advanced levels in North America, China, and other areas around the globe. This expertise enables the firm to effectively identify and support high-potential healthcare companies, fostering innovation and growth in the sector.
Investment Focus
- Focus on healthcare sector
- Cross-border opportunities between US and China
- Companies with promising growth potential
- Alignment with healthcare innovation
Portfolio Companies
Reach YuanMing Capital directly
Verified work email, phone and LinkedIn for the full team — one spreadsheet, one payment, yours to keep.
Unlock full contacts →Frequently asked questions about YuanMing Capital
What sectors does YuanMing Capital invest in?
YuanMing Capital invests in Healthcare, Healthcare Services, Medical Devices, Diagnostics and Biotechnology, and is based in Beijing, China. YuanMing Capital is listed as a private equity in the ConnectSafely investor database.
What stage does YuanMing Capital invest at?
YuanMing Capital backs companies at Early Stage, Growth, Late Stage, Pre-IPO and Buyout.
Which regions does YuanMing Capital invest in?
YuanMing Capital invests across United States and China.
What companies has YuanMing Capital invested in?
YuanMing Capital's portfolio includes Mevion Medical Systems and Waveguide.
How do I contact YuanMing Capital?
YuanMing Capital's contact details — including LinkedIn — are listed in the ConnectSafely investor database, along with its website and the LinkedIn profiles of the team.
Last updated · Source: ConnectSafely investor database
